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Abstract
Aim We hypothesized that participant well-being and satisfaction with services would be positively associated with a
satisfactory clinical course during transition from child to adult health care.
Methods Some 150 young people with Type 1 diabetes mellitus from five diabetes units in England were recruited to a
longitudinal study of transition. Each young person was visited at home four times by a research assistant; each visit was
1 year apart. Satisfaction with services (Mind the Gap; MTG) and mental well-being (Warwick–Edinburgh Mental Well-
being Scale; WEMWBS) were captured. Change in HbA1c, episodes of ketoacidosis, clinic and retinal screening attendance
were used to assess clinical course. In total, 108 of 150 (72%) young people had sufficient data for analysis at visit 4.
Results Mean age at entry was 16 years. By visit 4, 81.5% had left paediatric healthcare services. Median HbA1c
increased significantly (P = 0.01) from 69 mmol/mol (8.5%) at baseline to 75 mmol/mol (9.0%) at visit 4. WEMWBS
scores were comparable with those in the general population at baseline and were stable over the study period. MTG
scores were also stable. By visit 4, some 32 individuals had a ‘satisfactory’ and 76 a ‘suboptimal’ clinical course. There
were no significant differences in average WEMWBS and MTG scores between the clinical course groups (P = 0.96, 0.52
respectively); nor was there a significant difference in transfer status between the clinical course groups.
Conclusions The well-being of young people with diabetes and their satisfaction with transition services are not closely
related to their clinical course. Investigating whether innovative psycho-educational interventions can improve the
clinical course is a research priority.
Diabet. Med. 00: 1–7 (2018)
Introduction
‘Transition’ is the purposeful, planned process that addresses
the medical, psychosocial and educational/vocational needs
of adolescents and young adults with long-term conditions as
they move from child-centred to adult-oriented healthcare
systems [1]. Transition usually occurs during adolescence, a
time of important change in an individual’s physiology,
psychology and for societal expectations [2,3]. These changes
and pressures are associated with potentially detrimental
effects on health behaviours such as service engagement, and
on biological markers of disease control.
Deteriorating glycaemic control is well-recognized in
adolescents with Type 1 diabetes mellitus [4,5] with an
associated increase in acute complications [6]. Although the
deterioration is usually followed by an improvement in the
third decade of life, a period of poor glycaemic control has a
significant impact on a range of health indices, such as
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the risk of microvascular complications many years later
[7,8].
Improving transitional care for young people has the
potential to improve health for many years to come, but
the factors that influence this process from the perspective of
the individual and healthcare professional are poorly
understood.
The well-being of patients and their satisfaction with the
transition services provided are two outcomes of importance
to young people [9] and clinicians [10,11]. As well as being
intrinsically worthwhile, it is also hoped that achievement of
these outcomes makes a satisfactory clinical course more
likely (defined later to include markers of HbA1c, ketoaci-
dosis, clinic and retinal screening attendance). However, it is
unclear whether this is so. Reduced well-being in rheuma-
tological problems is associated with more active disease [12]
but in diabetes the picture is less clear with two studies
showing no associations [13,14], and another showing a
positive association between well-being and better disease
control as measured by HbA1c [15]. De Wit et al. [14] also
found no association between HbA1c and satisfaction with
care. We hypothesized that young people with Type 1
diabetes and higher well-being would be more likely to
experience a satisfactory clinical course during transition
than those with lower well-being. Similarly, we hypothesized
that young people who were more satisfied with their health
service provision would be more likely to experience a
satisfactory clinical course.
Participants and methods
Data on young people with Type 1 diabetes were available
from a longitudinal study of the transition of young people
with long-term conditions from child to adult health services
[16], which was itself part of a 5-year programme of research
on transition (http://research.ncl.ac.uk/transition/). Data had
been captured from young people with one of three long-
term conditions, cerebral palsy, autism spectrum disorder or
diabetes, over a 3-year period of healthcare transition.
Eligible young people, aged between 14 years and 18 years
11 months who were without significant learning difficulties
were recruited from five hospital sites across England that are
responsible for all young people with Type 1 diabetes in their
area. All units used the diabetes tariff as a structure for
implementing a high-quality programme of diabetes care [17].
The tariff includes guidance regarding care components such
as frequency and nature of patient contact, HbA1c measure-
ment (four times per year) and highlights the importance of a
clear policy regarding transition to adult services.
At recruitment, the young people had not transferred to
adult services but were anticipated to do so during the study
[16]. Young people were visited at home by research
assistants on four occasions, 1 year apart. At each visit,
questionnaires about satisfaction with services and mental
well-being were completed by the young person. Also, the
following variables concerning the previous year were
collected by the research assistants from medical notes:
mean HbA1c, clinic attendance, hospital admissions for
diabetic ketoacidosis and attendance for annual retinal
screening.
The young people taking part in the study did not differ
significantly from those who declined to take part by age or
gender [18]. Those taking part had significantly (P < 0.001)
lower scores on a socio-economic deprivation index (i.e. less
deprived) than those who declined; however, the difference
in overall Index of Multiple Deprivation score on a contin-
uous scale ranging from 0.5 to 87.8, was only 6.1 [18]. Based
on data from the National (England and Wales) Paediatric
Diabetes Audit for year 2011/2012 [19], at recruitment,
those participating were representative of the England and
Wales population of young people with Type 1 diabetes in
respect of age at diagnosis and mean HbA1c in the previous
year [19].
Mental well-being
Mental well-being was assessed using the Warwick–Edin-
burgh Mental Well-being Scale (WEMWBS) [20] completed
independently by the young person at the annual visit by the
research assistant. This scale includes 14 positively worded
phrases with a five-category Likert scale response option
from ‘none of the time’ to ‘all of the time’; this yields a score
from 14 to 70, with higher scores indicating higher mental
well-being. The scale was developed and validated in the UK,
including its use with young people aged 13–18 years [21].
Satisfaction with healthcare services during transition
The Mind the Gap (MTG) scale [22] was developed in the
UK to evaluate satisfaction with services in adolescents with
long-term health conditions. The 22-item questionnaire asks
participants to rate their perception of current care and
expectation of best care. All questionnaire items are scored
on a seven-point Likert scale anchored by ‘strongly disagree’
at 1 and ‘strongly agree’ at 7. Satisfaction with each item is
conceptualized as ‘the gap’ between best and current care for
all questionnaire items. The overall score ranges from 6
What’s new?
• Well-being and satisfaction with services were stable
during a 3-year longitudinal study of young people with
Type 1 diabetes mellitus in transition to adult services.
• Well-being and satisfaction with services were not
related to HbA1c or the more general clinical course.
• Further work is needed to identify innovative and
effective psycho-educational interventions to improve
the clinical course.
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most satisfied to +6 most unsatisfied with a score of 0
reflecting ‘no gap’ between current and best care. The
instrument has demonstrated internal consistency with a
Cronbach’s alpha of 0.91 [22].
Clinical course during transition
There is no consensus on how best to assess a satisfactory
clinical course during transition. Following discussion among
the authors, the wider Transition Research Collaborative
group and a review of the literature [11,23,24], a set of
criteria based on collected clinical and attendance data was
established to define a satisfactory clinical course. The four
markers were: glycaemic control (HbA1c), any episode of
diabetic ketoacidosis, clinic attendance and retinal screening
attendance.
Up to four HbA1c values were recorded each year and
these were extracted from the medical notes. The mean of
these measurements each year was calculated. We chose an
increase in HbA1c (measured in mmol/mol) of > 7% from
baseline to be a marker of suboptimal glycaemic control in
order to account for analytic variance and intra-individual
variation in measurement [25,26]. The second marker of
clinical course was the presence or absence of hospital
admissions with ketoacidosis. The third marker was a > 75%
attendance each year for clinics scheduled as a standard of
care and additional ones where clinically indicated. This
figure was selected to allow for appointments being missed
inadvertently. The fourth marker was attendance at retinal
screening each year because this reflects both engagement
with services and positive health behaviour.
Participants were assigned to the ‘satisfactory clinical
course group’ if, at the final visit 4, their HbA1c was < 7%
above the baseline value; and over the 3 years they had no
admissions with ketoacidosis, they had > 75% clinic atten-
dance each year and had attended for retinal screening each
year; they were categorized as having a ‘suboptimal clinical
course’ if they did not meet all the criteria.
The study received a favourable ethics opinion from the
Newcastle and North Tyneside1 Research Ethics Committee
12/NE/0059.
Statistical analysis
Participant satisfaction, well-being and HbA1c were analysed
as continuous variables, whereas clinic attendance, retinal
screening and episodes of ketoacidosis were analysed as
categorical variables. Wilcoxon signed ranks test was used to
compare HbA1c between baseline (visit 1) and visit 4.
The correlations of both WEMWBS and MTG with HbA1c
anddurationof diabeteswere investigatedusing Pearsonproduct
moment correlation coefficient. WEMWBS and MTG scores
were tested for association with the satisfactory and suboptimal
clinical course groups using the Mann–WhitneyU-test. The chi-
squared test was used to compare the gender distribution in the
two clinical course groups.MTG andWEMWBS scores of those
recruitedwhodid anddid not complete the studywere compared
using independent samples t-tests.
This study was powered to detect a difference in the
chosen variables; for example, to recognize a change of 1.5 in
the WEMWBS at a 5% significance level using the general
population mean of 48.8 (SD 6.8).
Results
Some 150 young people with Type 1 diabetes were recruited;
108 (72%) had complete data through to visit 4 and
constituted the group for analysis. There were no significant
differences in the baseline details of age, gender or duration
of diabetes between the 150 young people recruited and the
108 with complete data through to visit 4 (Table 1). Of the
42 young people not remaining in the study, 14 were lost to
follow-up and 28 withdrew. Of those withdrawing, 23 said
they were no longer interested and five had changes in
external physical or emotional circumstances, such as a road
traffic accident or a parent dying or developing cancer, which
made it difficult to continue.
There were no significant differences in the MTG or
WEMWBS scores at the baseline visit between those recruited
and those with complete data to visit 4 (t(148) = 1.14,
P = 0.26 and t(146) = 1.85, P = 0.66) (data not shown).
Some 81.4% of those with complete data had left paedi-
atric health care services by visit 4, of whom three had follow-
up with their general practitioner and the remainder had
transferred to secondary hospital healthcare services.
Median annual HbA1c values increased over the study
period and were significantly higher at visit 4 than at visit 1.
Visit 1: 69.2 mmol/mol, i.q.r. 19 (8.5%); visit 2: 72.2 mmol/
mol, i.q.r. 24 (8.8%); visit 3: 70.0 mmol/mol, i.q.r. 24
(8.6%) and visit 4: 74.8 mmol/mol, i.q.r. 19 (9%) (Wilcoxon
signed rank test Z = 2.44, P = 0.01).
Mean annual WEMWBS scores did not change signifi-
cantly over the study period (P = 0.97). There was no
significant correlation between mean visit 4 WEMWBS and
either HbA1c (r = 0.13, N = 92, P = 0.22) or duration of
diabetes (r = 0.05, N = 97, P = 0.61).
Mean annual MTG scores did not change significantly
over the study period (P = 0.28). There was no significant
correlation between visit 4 MTG score and HbA1c (r = 0.02,
N = 87, P = 0.83).
Table 2 shows the number of young people (from the 108
who completed the study) who did not meet the criterion for
each marker in the year before each visit.
Comparison of the clinical course subgroups
There were 32 young people in the satisfactory clinical
course group and 76 in the suboptimal group. The two
groups were comparable for disease duration (Table 3).
There was a greater proportion of men than women in the
ª 2018 The Authors.
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satisfactory group (difference not significant, P = 0.17). By
visit 4, 87.5% in the satisfactory group and 78.9% in the
suboptimal group had transferred to adult services (differ-
ence not significant, chi square 1.09; P = 0.3). There was no
significant difference in the average WEMWBS score
(U = 955, P = 0.52) or average MTG score (U = 908,
P = 0.96) between the groups. The most common criteria
for allocation to the suboptimal group were ‘less than 75%
clinic attendance’ and ‘increase in HbA1c’. Fifteen young
people had hospital admission for ketoacidosis during the
study. In the suboptimal group 43 of 76 met only one
criterion; (17 clinic attendance, 13 HbA1c, 6 ketoacidosis, 7
retinal screening). Some 24 of 76 young people met only two
criteria, most frequently HbA1c and clinic attendance; 9 of 76
met three criteria.
Discussion
We found no evidence that the mental well-being and
satisfactionwith services of young peoplewith Type 1 diabetes
were associatedwith a satisfactory clinical course as defined by
the four clinical markers HbA1c, ketoacidosis, clinic and
retinal screening attendance. The median HbA1c increased
significantly during the 4-year study period but this also was
not associated with mental well-being or satisfaction with
services. The mental well-being of those with Type 1 diabetes
was similar to that of the general population of 13–16-year-
olds in England and Scotland [21] and did not change
significantly over time. Scores of satisfaction with services
were comparable with published data of adolescents with
long-term conditions during transition [22]. Participant satis-
faction did not change significantly over time. In summary,
mental well-being and satisfaction with healthcare services
were good and were not associated with the clinical course,
which was suboptimal in 70% of young people in this study.
There is no consensus about what constitutes a ‘satisfac-
tory clinical course’ in Type 1 diabetes during transition,
from an adolescent or clinician perspective. Our assessment
was based on biological markers of disease control as well as
markers of engagement. Change in HbA1c was included
because it is a key biological marker of disease control in
Type 1 diabetes. A systematic review of interventions that
Table 1 Baseline demographic details of all participants recruited and the 108 participants with complete data to visit 4
Total participants recruited
Participants with
complete data to visit 4
Participants with
incomplete data to visit 4
N = 150 N = 108 N = 42
Gender, n (%)
Men 77 (51.3) 53 (49.1) 24 (57)
Women 73 (48.7) 55 (50.9) 18 (43)
Mean (SD) age at study entry in years 16.2 (1.3) 16.0 (1.3) 16.5 (1.2)
Median (IQR) disease duration in years 6.7 (5.3) 7.5 (5.8) 5.1 (5.4)
Mean (SD) age at diagnosis in years (range 1–16 years) 9.5 (3.8) 8.5 (3.8) 10.8 (3.0)
Outcome at visit 4, n (%)
Transferred to adult services 100 (66.7) 88 (81.5) 12 (28)
Paediatric services 26 (17.3) 19 (17.6) 7 (17)
Outcome unknown 24 (16.0) 1 (0.9) 23 (55)
Table 2 Number of participants (from the 108 who completed the
study) that did not meet the criterion for each marker in the year before
each visit.
Marker Visit 2 Visit 3 Visit 4
Not met target of HbA1c
difference from baseline
visit, n (%)
23 (21.3) 20 (18.5) 34 (31.5)
One or more episodes of
diabetic ketoacidosis, n (%)
7 (6.5) 8 (7.4) 3 (2.8)
< 75% paediatric clinic
attendance, n (%)
23 (21.3) 14 (13.0) 20 (18.5)
Not received annual retinal
screening, n (%)
10 (9.3) 4 (3.7) 16 (14.8)
Table 3 Baseline demographic data, Mind the Gap score and mental
well-being score by clinical course group
Satisfactory
clinical course
Suboptimal
clinical
course
N = 32 N = 76
Mean (SD) age at baseline in years 15.8 (1.1) 16.1 (1.2)
Median (IQR) age at
diagnosis in years
9.0 (6.0) 9.0 (6.0)
Median (IQR) duration of
diabetes in years
6.5 (6.0) 7.0 (6.0)
Men 59.4% 44.7%
Women 40.6% 55.3%
Average Mind the Gap score (IQR)
Baseline (visit 1) 0.57 (1.6) 0.50 (1.1)
Visit 4 0.64 (1.2) 0.61 (1.1)
Average Mental wellbeing score (SD)
Baseline (visit 1) 53.5 (8.5) 52.9 (8.0)
Visit 4 52.6 (8.3) 53.2 (7.3)
Transferred to adult services 87.5% 78.9 %
None of the differences between the two groups was statisti-
cally significant, P > 0.05.
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improve transition to adult care in adolescents with Type 1
diabetes noted that 16/18 studies included HbA1c as an
outcome [24]. Our justification for using ketoacidosis was
that episodes are associated with poor disease control and
poor adherence to treatment [6]. We considered clinic
attendance to be an important part of satisfactory transi-
tional care because it correlates with a better disease outcome
[23]. Clinic and annual retinal screening attendance are
markers of positive health behaviour and are both recom-
mended by the National Institute of Health and Care
Excellence (NICE) guidelines for transition services and
management of young people with diabetes [27].
The median HbA1c increased significantly during the study
period. This has been reported in previous studies – a trend
of deteriorating glycaemic control during adolescence with
subsequent improvement, plateauing by about age 30 years
[4,5]. During the study, 81% of the young people transferred
to adult healthcare services. Similar proportions of those who
had and had not transferred were in each clinical course
group, raising the possibility that healthcare transfer may not
be relevant to this deterioration in metabolic control.
Deterioration of glycaemic control during adolescence may
be related to hormonal changes and insulin resistance.
However, a study by Morris et al. [6] involving adolescents
found increases in HbA1c were associated with deteriorations
in adherence to treatment, as demonstrated by reductions in
volumes of insulin administered.
Participant satisfaction with services did not change
significantly over time and was not related to the clinical
course. Satisfaction with services was comparable with that
of young people with another long-term condition (rheuma-
tological disorders during transition) [22] and in an evalu-
ation of an intervention in transitional care for young people
with juvenile idiopathic arthritis [28]. This suggests that
some adolescents with Type 1 diabetes are not aware of the
optimal clinical course they should expect and are therefore
happy with the service they receive.
The mental well-being of those with Type 1 diabetes was
similar to that of the general population of 13–16-year-olds
in England and Scotland [21]. Mental well-being did not vary
during the period of transition, suggesting that healthcare
transition per se is not detrimental to well-being. Finally,
there was no association between well-being and clinical
course. This is not the case for juvenile idiopathic arthritis
where there is an association between disease activity and
health-related quality of life [12]. In Type 1 diabetes there is
in general no development of adverse symptoms in response
to suboptimal glycaemic control and this may explain why
well-being is not affected.
We chose to measure general well-being for three reasons:
(1) it enables comparisons to be made across conditions; (2)
international Delphi studies indicated that this was regarded
as an important outcome of transition, not hitherto addressed
[10]; and (3) diabetes-specific quality of life instruments tend
to capture negative consequences of disease, which may bear
little relation to the overall well-being of an individual. Vallis
et al. [29] found that young people with Type 1 diabetes aged
18–25 years had better overall well-being than those aged
over 30 years but more diabetes-specific distress. Diabetes-
specific quality of life, although often reduced, may also bear
little relation to markers of disease control, such as HbA1c
[13]. Further, an intervention which improved health-related
quality of life failed to demonstrate a subsequent improve-
ment in glycaemic control [14].
Why might it be that, although well-being was good and
services were appreciated, the clinical course and in partic-
ular glycaemic control deteriorated in two-thirds of the
population? A systematic review of the impact of transition
processes and experiences on outcomes in Type 1 diabetes
[30] identified three superordinate themes from qualitative
studies with young people: ‘Discontinuity of care’, ‘Practical
issues with transitional care’ and ‘Renegotiating responsibil-
ity for self-management’. Compared with some of the studies
from North America cited in the review, discontinuity of care
in Type 1 diabetes in the UK is not a significant problem and
this was borne out in our study. Also, practical issues with
transition seem not to have been problematic in our study as
the MTG scale indicated general satisfaction with services.
Renegotiating responsibility for self-management may be
worthy of further study. But even this may not work if
adolescents view their disease burden to be less than that
perceived by parents or health professionals. An intense
psycho-educational programme was found to have no effect
on HbA1c [31] and a systematic review in 2017 found there
was insufficient evidence to recommend any psycho-educa-
tional programme [32].
Other important changes during this phase of life are the
shift in importance from parent to peer relationships and the
development of autonomy and independent coping skills.
However, there is increasing evidence that parents remain
important in health management [33,34] and that renegoti-
ation of responsibility should be gradual and is unlikely to be
complete by the time of transfer to the adult service. Further,
although there is interest in peer support interventions,
young people with diabetes who believe they would experi-
ence a negative reaction from their peers in social situations
have reduced adherence, with a subsequent deterioration in
glycaemic control [35].
Strengths and weaknesses
Our study captured data during the healthcare transition
process, rather than at a time when transition is complete at
around age 24 years. Although assessment of longer term
outcome is important, changes to transition programmes
must take place during transition and therefore the percep-
tions of young people and the control of their diabetes during
this time are important to understand.
The original sample had lower recruitment from areas with
more socio-economic deprivation, although, as mentioned
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above, the difference was small. We followed the group of
young people for 3 years. Although 42 adolescents with
incomplete data could not be included in the analysis, they
did not differ significantly in demographic characteristics or
baseline variables from those with complete data.
The proportion of adolescents in the clinical course groups
reflects the data collected as part of the study and does not
necessarily cover every important parameter, such as
episodes of severe hypoglycaemia, recording of annual blood
pressure or renal status.
To conclude, mental well-being and satisfaction with
healthcare services were good in this sample of young people
with Type 1 diabetes, and were not associated with the
clinical course, which was suboptimal in 70% of those taking
part. Developmental changes may have more influence on the
clinical course than transition per se. There remains a need to
improve the support for young people to develop confidence
in managing their condition, to help them benefit from peer
support and to address any difficulties they may have with
peers and family. The best ways to do this remain unclear
and there is a need for evaluation of innovative interventions
to address these issues.
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